tiprankstipranks
Advertisement
Advertisement

XTNT Stock Latest News

Xtant Medical lowers 2026 revenue view to $99M-$103M from $101M-$105M
The FlyXtant Medical lowers 2026 revenue view to $99M-$103M from $101M-$105M
9d ago
XTNT
Xtant Medical Stockholders Approve Governance and Leadership Items
PremiumCompany Announcements
Xtant Medical Stockholders Approve Governance and Leadership Items
13d ago
8K
XTNT
Xtant Medical Balances New Growth Bets With Near-Term Pain
PremiumCompany Announcements
Xtant Medical Balances New Growth Bets With Near-Term Pain
3M ago
XTNT
Xtant Medical’s HEMOBLAST Deal with Dilon: High Sales Spend, Single‑Supplier Dependence and Termination Risk Threaten Returns
PremiumCompany Announcements
Xtant Medical’s HEMOBLAST Deal with Dilon: High Sales Spend, Single‑Supplier Dependence and Termination Risk Threaten Returns
3M ago
XTNT
Xtant Medical Boosts 2026 Outlook Amid Tough Quarter
PremiumCompany Announcements
Xtant Medical Boosts 2026 Outlook Amid Tough Quarter
3M ago
XTNT
Xtant Medical reports Q1 EPS (2c) vs. 0c last year
PremiumThe FlyXtant Medical reports Q1 EPS (2c) vs. 0c last year
3M ago
XTNT
Xtant Medical raises FY26 revenue view to $101M-$105M from $95M-$99M
Premium
The Fly
Xtant Medical raises FY26 revenue view to $101M-$105M from $95M-$99M
3M ago
XTNT
Xtant Medical Updates Q1 Results and Raises 2026 Guidance
Premium
Company Announcements
Xtant Medical Updates Q1 Results and Raises 2026 Guidance
3M ago
8K
XTNT
Xtant Medical resumed with a Buy at Maxim
PremiumThe Fly
Xtant Medical resumed with a Buy at Maxim
4M ago
XTNT
Xtant Medical Expands Portfolio with HEMOBLAST Distribution Deal
PremiumCompany Announcements
Xtant Medical Expands Portfolio with HEMOBLAST Distribution Deal
4M ago
8K
XTNT
Xtant Medical acquires U.S. distribution rights to Dilon’s Hemoblast Bellows
PremiumThe Fly
Xtant Medical acquires U.S. distribution rights to Dilon’s Hemoblast Bellows
4M ago
XTNT
Xtant Medical Warns of 2026 Profit Hit as One‑Time License Revenue and SimpliMax™ Reimbursements Fade
PremiumCompany Announcements
Xtant Medical Warns of 2026 Profit Hit as One‑Time License Revenue and SimpliMax™ Reimbursements Fade
5M ago
XTNT
Xtant Medical Earnings Call Highlights Profitability Turnaround
PremiumCompany AnnouncementsXtant Medical Earnings Call Highlights Profitability Turnaround
5M ago
XTNT
Xtant Medical reports Q4 EPS 0c vs. (2c) last year
Premium
The Fly
Xtant Medical reports Q4 EPS 0c vs. (2c) last year
5M ago
XTNT
Xtant Medical sees 2026 revenue $95M-$99M, consensus $110.1M
Premium
The Fly
Xtant Medical sees 2026 revenue $95M-$99M, consensus $110.1M
5M ago
XTNT
XTNT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
XTNT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
XTNT
Xtant Medical Boosts Liquidity After Companion Spine Repayment
PremiumCompany Announcements
Xtant Medical Boosts Liquidity After Companion Spine Repayment
6M ago
8K
XTNT
Xtant Medical says transactions with Companion Spine now finalized
PremiumThe Fly
Xtant Medical says transactions with Companion Spine now finalized
6M ago
XTNT
Xtant Medical Extends Note Maturity After Asset Divestitures
PremiumCompany Announcements
Xtant Medical Extends Note Maturity After Asset Divestitures
7M ago
8K
XTNT
Xtant Medical announces commercial launch of Strata
PremiumThe FlyXtant Medical announces commercial launch of Strata
8M ago
XTNT
Xtant Medical Sells Assets to Companion Spine
Premium
Company Announcements
Xtant Medical Sells Assets to Companion Spine
9M ago
8K
XTNT
Xtant Medical Reports Strong Q3 2025 Results
Premium
Company Announcements
Xtant Medical Reports Strong Q3 2025 Results
9M ago
XTNT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >